Across the three AD cases, the highest burden of tau immunoreactivity was found in the H‐AD case, followed by a progressive decrease in staining in the I‐AD case and then the L‐AD cases in the temporal and hippocampal regions. This evidence concerns the gene MAPT and Alzheimer disease.